Synapse - Christopher Forlenza

Search Within

Christopher Jon Forlenza

Results (49)

Venetoclax alone or in combination with chemotherapy in paediatric and adolescent/young adult patients with relapsed/refractory acute myeloid leukaemia

Journal Article

Karol, S. E.; Khaw, S. L.; Zwaan, C. M.; Baruchel, A.; Bittencourt, H.; Cooper, T. M.; Flotho, C.; Fraser, C.; Forlenza, C. J.; Goldsmith, K. C.; more...
Pediatric Blood and Cancer (2025)

Fulltext@MSK | Save

Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era

Journal Article

Marks, L. J.; Ritter, V.; Agrusa, J. E.; Kamdar, K. Y.; Rivers, J.; Gardner, R.; Ehrhardt, M. J.; Devine, K. J.; Phillips, C. A.; Reilly, A.; more...
Blood Advances (2025)

Fulltext@MSK | Save

Venetoclax combined with chemotherapy in pediatric and adolescent/young adult patients with relapsed/refractory acute lymphoblastic leukemia

Journal Article

Place, A. E.; Karol, S. E.; Forlenza, C. J.; Cooper, T. M.; Fraser, C.; Cario, G.; O'Brien, M. M.; Gerber, N. U.; Bourquin, J. P.; Reinhardt, D.; more...
Pediatric Blood and Cancer (2025)

Fulltext@MSK | Save

Treatment of T-cell leukemia/lymphoma in children and young adults with the Memorial Sloan Kettering Cancer Center New York IIB protocol

Journal Article

Steinherz, P. G.; Mauguen, A.; Suser, S.; Ramaswamy, K.; Kobos, R.; Forlenza, C. J.; Shukla, N.; Trippett, T.; Wolden, S.; Steinherz, L.
Journal of Pediatric Hematology/Oncology (2025)

Fulltext@MSK | Save

Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings

Research Letter

Ceyhan-Birsoy, O.; Fiala, E.; Rana, S.; Sheehan, M.; Kennedy, J.; Yelskaya, Z.; Rai, V.; Li, Y.; Yang, C.; Wong, D.; more...
Haematologica (2024)

Fulltext@MSK | Save

The pediatric approach to Hodgkin lymphoma

Review

Heneghan, M. B.; Belsky, J. A.; Milgrom, S. A.; Forlenza, C. J.
Seminars in Hematology (2024)

Fulltext@MSK | Save

Implementation of transmission-based precaution contingency guidelines in an outpatient pediatric oncology clinic during a regional respiratory virus surge

Meeting Abstract

McClure, T.; Aslam, A.; Kamboj, M.; Bright, R.; Lane, M.; Forlenza, C.
American Journal of Infection Control (2024)

Fulltext@MSK | Save

Progression-free survival (PFS) and toxicity with nivolumab-AVD compared to brentuximab vedotin-AVD in pediatric advanced stage (AS) classic Hodgkin lymphoma (cHL), results of SWOG S1826

Meeting Abstract

Castellino, S. M.; Li, H.; Herrera, A. F.; Punnett, A.; Leblanc, M.; Parsons, S. K.; Hodgson, D.; Keller, F.; Drachtman, R. A.; Lamble, A.; more...
Blood (2023)

Fulltext@MSK | Save

Results from an intergroup randomized phase II study of the combinations of ipilimumab, nivolumab and brentuximab vedotin in patients with relapsed/refractory classic Hodgkin lymphoma: A trial of the ECOG-ACRIN Research Group (E4412)

Meeting Abstract

Diefenbach, C. S.; Jegede, O.; Ansell, S. M.; Steidl, C.; Natkunam, Y.; Scott, D. W.; Mehta-Shah, N.; Amengual, J. E.; Forlenza, C. J.; Cole, P. D.; more...
Blood (2023)

Fulltext@MSK | Save

Pembrolizumab (pembro) in children and young adults with low-risk classical Hodgkin lymphoma (cHL) with slow early response (SER) to front-line chemotherapy (chemo): Early results from the phase 2 KEYNOTE-667 study

Meeting Abstract

Roth, L. G.; Keller, F.; Toledo, M. M.; Castellino, S. M.; Forlenza, C. J.; Catalan, M. A.; Krystal, J.; Lamble, A.; Rao, A. V.; Morales, F. M.; more...
Blood (2023)

Fulltext@MSK | Save